As of February 2025 Aclaris Therapeutics has a market cap of NZ$0.37 Billion. This makes Aclaris Therapeutics the world's 8068th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$0.37 B | -26.69% |
2024 | NZ$0.51 B | 340.47% |
2023 | NZ$0.11 B | -92.89% |
2022 | NZ$1.65 B | 26.92% |
2021 | NZ$1.30 B | 222.23% |
2020 | NZ$0.40 B | 247.44% |
2019 | NZ$0.11 B | -74.36% |
2018 | NZ$0.45 B | -57.59% |
2017 | NZ$1.07 B | 4.9% |
2016 | NZ$1.02 B | 28.64% |
2015 | NZ$0.79 B |
On Feb 24th, 2025 the market cap of Aclaris Therapeutics was reported to be: